Endoscopic Sleeve Gastroplasty (ESG) has shown significant promise in managing obesity-related comorbidities, as evidenced by a prospective 5-year study. Here are the key findings related to its impact: ### 1.
Endoscopic Sleeve Gastroplasty (ESG) has shown significant promise in managing obesity-related comorbidities, as evidenced by a prospective 5-year study. Here are the key findings related to its impact:
### 1. **Weight Loss**
### 2. **Improvement in Obesity-Related Comorbidities**
ESG demonstrated substantial improvements in several obesity-related conditions:
### 3. **Reduced Medication Dependence**
### 4. **Minimally Invasive and Long-Term Efficacy**
### Conclusion
The study underscores ESG as an effective therapeutic option for addressing both obesity and its associated comorbidities. By improving key metabolic markers, reducing medication reliance, and achieving sustained weight loss, ESG offers a comprehensive and minimally invasive approach to managing obesity and its related health challenges.
Introduction: Endoscopic metabolic therapies have emerged as less invasive alternatives to bariatric surgery for patients with obesity and poorly controlled type 2 diabetes mellitus (T2DM). The EndoBarrier duodenal-jejunal bypass liner (DJBL) is an endoscopically placed...
Introduction: Endoscopic ultrasound (EUS)-guided transmural drainage is the standard minimally invasive treatment for symptomatic necrotizing pancreatitis. However, the optimal timing of direct endoscopic necrosectomy (DEN) following drainage remains uncertain. While the conventional step-up approach reserves...
Introduction: Bevacizumab is widely used in metastatic colorectal cancer (mCRC) because of its survival benefits but is associated with impaired wound healing, gastrointestinal perforation, and bleeding. These concerns often lead clinicians to delay endoscopic procedures...
Introduction: Endoscopic submucosal dissection (ESD) enables en bloc resection of large colorectal neoplasms with excellent oncological outcomes. However, concerns about perforation have limited its widespread adoption. This large prospective multicenter study evaluated the incidence, risk...
Introduction: Obesity has become one of the greatest global health challenges. New incretin-based therapies—including semaglutide, tirzepatide, resmetirom, and SGLT2 inhibitors such as empagliflozin—have transformed the treatment of obesity, diabetes, and MASLD. However, many patients discontinue...
Introduction: Endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) is the standard technique for diagnosing solid pancreatic lesions. Traditionally, biopsy specimens are processed for cytology, often requiring on-site cytopathology support. This multicenter prospective study evaluated whether directly placing...
We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.